Lassen, Michael Rud <br/><br/>
Apixaban versus enoxaparin for thromboprophylaxis after hip replacement.  [electronic resource] 

 -  The New England journal of medicine  Dec 2010 
 - 2487-98 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1533-4406 
<br/><br/><label>Standard No.: </label>10.1056/NEJMoa1006885  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Anticoagulants--adverse effects<br/>Arthroplasty, Replacement, Hip<br/>Confidence Intervals<br/>Double-Blind Method<br/>Enoxaparin--adverse effects<br/>Factor Xa Inhibitors<br/>Female<br/>Hemorrhage--chemically induced<br/>Humans<br/>Injections, Subcutaneous<br/>Male<br/>Middle Aged<br/>Postoperative Complications--prevention & control<br/>Pyrazoles--adverse effects<br/>Pyridones--adverse effects<br/>Treatment Outcome<br/>Venous Thromboembolism--prevention & control<br/>Young Adult